About Us
ACT GENOMICS BIOTECHNOLOGY (HONG KONG) LTD.
ACT Genomics is a leading biotechnology company in Asia providing genomics test service in oncology. We solve fundamental challenges in cancer diagnostics, and translate next generation sequencing (NGS) test results into tailored treatment options. Our experts with solid experience in cancer biology, cancer genomics, high content sequencing, bioinformatics, and drug development, enable ACT Genomics to overcome the hurdles widely found in today’s cancer diagnostics. To understand more information about ACT Genomics, please visit our website at www.actgenomics.com.
Our services in Hong Kong are highly recognized by the BioTech and Medical Healthcare sectors since its establishment in early 2017. Our Company will move into the Hong Kong Science and Technology Park in the second quarter of 2018. To cope with our rapid business expansion, we would like to invite dynamic and highly qualified candidates to develop their careers together with us.